MGLN
Income statement / Annual
Last year (2020), Magellan Health, Inc.'s total revenue was $4.58 B,
a decrease of 36.06% from the previous year.
In 2020, Magellan Health, Inc.'s net income was $4.05 M.
See Magellan Health, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
FY-2012
|
FY-2011
|
| Period Ended |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
12/31/2012 |
12/31/2011 |
| Operating Revenue |
$4.58 B
|
$7.16 B
|
$7.31 B
|
$5.84 B
|
$4.84 B
|
$4.60 B
|
$3.76 B
|
$3.55 B
|
$3.21 B
|
$2.80 B
|
| Cost of Revenue |
$4.46 B |
$6.93 B |
$7.12 B |
$5.57 B |
$4.58 B |
$4.42 B |
$3.55 B |
$3.31 B |
$2.96 B |
$2.02 B |
| Gross Profit |
$118.79 M |
$229.29 M |
$197.18 M |
$271.02 M |
$258.94 M |
$178.38 M |
$215.08 M |
$238.19 M |
$249.58 M |
$782.64 M |
| Gross Profit Ratio |
0.03 |
0.03 |
0.03 |
0.05 |
0.05 |
0.04 |
0.06 |
0.07 |
0.08 |
0.28 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$876.61 M
|
$822.39 M
|
$723.50 M
|
$619.55 M
|
$557.51 M
|
$529.63 M
|
| Other Expenses |
$98.39 M |
$131.51 M |
$132.66 M |
$115.71 M |
-$770.57 M |
-$719.55 M |
-$632.43 M |
-$547.55 M |
-$497.02 M |
$58.62 M |
| Operating Expenses |
$98.39 M |
$131.51 M |
$132.66 M |
$115.71 M |
$106.05 M |
$102.84 M |
$91.07 M |
$71.99 M |
$60.49 M |
$588.26 M |
| Cost And Expenses |
$4.56 B |
$7.06 B |
$7.25 B |
$5.68 B |
$4.68 B |
$4.52 B |
$3.64 B |
$3.38 B |
$3.02 B |
$2.61 B |
| Interest Income |
$4.05 M |
$19.19 M |
$14.07 M |
$5.89 M |
$2.82 M |
$2.17 M |
$1.30 M |
$1.99 M |
$2.02 M |
$2.78 M |
| Interest Expense |
$30.87 M |
$36.15 M |
$35.40 M |
$25.98 M |
$10.19 M |
$6.58 M |
$7.39 M |
$3.00 M |
$2.25 M |
$2.50 M |
| Depreciation &
Amortization |
$118.75 M
|
$131.51 M
|
$132.66 M
|
$115.71 M
|
$106.05 M
|
$102.84 M
|
$91.07 M
|
$71.99 M
|
$60.49 M
|
$58.62 M
|
| EBITDA |
$487.41 M
|
$248.48 M
|
$211.25 M
|
$276.97 M
|
$263.85 M
|
$183.25 M
|
$221.55 M
|
$240.18 M
|
$251.60 M
|
$255.79 M
|
| EBITDA Ratio |
0.11 |
0.03 |
0.03 |
0.05 |
0.05 |
0.04 |
0.06 |
0.07 |
0.08 |
0.09 |
| Operating Income Ratio
|
0.08
|
0.02
|
0.01
|
0.03
|
0.03
|
0.02
|
0.03
|
0.05
|
0.06
|
0.07
|
| Total Other
Income/Expenses Net |
-$409.15 M
|
-$36.15 M
|
-$35.40 M
|
-$26.04 M
|
-$12.28 M
|
-$9.29 M
|
-$12.56 M
|
-$3.00 M
|
-$2.25 M
|
-$2.50 M
|
| Income Before Tax |
-$40.49 M |
$80.82 M |
$43.19 M |
$135.22 M |
$145.52 M |
$71.12 M |
$117.92 M |
$165.19 M |
$188.87 M |
$194.66 M |
| Income Before Tax Ratio
|
-0.01
|
0.01
|
0.01
|
0.02
|
0.03
|
0.02
|
0.03
|
0.05
|
0.06
|
0.07
|
| Income Tax Expense |
-$44.53 M |
$24.92 M |
$19.01 M |
$25.08 M |
$69.73 M |
$42.41 M |
$43.69 M |
$39.92 M |
$37.84 M |
$65.04 M |
| Net Income |
$4.05 M |
$55.90 M |
$24.18 M |
$110.14 M |
$75.79 M |
$28.71 M |
$74.23 M |
$125.26 M |
$151.03 M |
$129.62 M |
| Net Income Ratio |
0 |
0.01 |
0 |
0.02 |
0.02 |
0.01 |
0.02 |
0.04 |
0.05 |
0.05 |
| EPS |
0.16 |
2.28 |
0.97 |
4.72 |
3.27 |
1.15 |
2.78 |
4.63 |
5.51 |
4.25 |
| EPS Diluted |
0.16 |
2.28 |
0.97 |
4.51 |
3.14 |
1.11 |
2.71 |
4.53 |
5.42 |
4.17 |
| Weighted Average Shares
Out |
$25.78 M
|
$24.56 M
|
$25.04 M
|
$23.33 M
|
$23.18 M
|
$24.87 M
|
$26.69 M
|
$27.05 M
|
$27.39 M
|
$30.48 M
|
| Weighted Average Shares
Out Diluted |
$25.78 M
|
$24.56 M
|
$25.04 M
|
$24.44 M
|
$24.16 M
|
$25.88 M
|
$27.36 M
|
$27.68 M
|
$27.88 M
|
$31.06 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
